New policy to ban pregnancies with genetically modified embryos
By The Yomiuri Shimbun,
The Japan News
| 04. 28. 2017
The government plans to drastically revise its basic policy on conducting research on human embryos, in an effort to implement state-led regulations on such research, The Yomiuri Shimbun has learned.
Aiming to meet the challenges posed by new technologies such as genome editing (see below) — a technology that efficiently alters genes — the government is considering limiting human embryo modification through genome editing to basic research, and prohibiting both the implantation of embryos with altered genes in a uterus and the live births of such embryos.
Concrete discussions will start in a new organization expected to be established under the Council for Science, Technology and Innovation chaired by Prime Minister Shinzo Abe. The government will make a decision on the establishment as early as May.
Compiled in 2004, the current basic policy on research using human embryos states that any handling of embryos that causes damage to them is not permitted. However, there is no specific provision for genome editing — an area in which research has intensified since the policy’s release — nor for nuclear transfer, a treatment...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...